Gonorrhea
Sexually Transmitted Disease
Surveillance 2007
Division of STD Prevention
Gonorrhea — Rates: United States, 1941–2007 and the Healthy People 2010 target
Rate (per 100,000 population)
500
Gonorrhea
2010 Target
400
300
200
100
0
1941 46 51 56 61 66 71 76 81 86 91 96 2001 06
Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000
population.
Gonorrhea — Rates: Total and by sex: United States, 1988–2007 and the
Healthy People 2010 target
Rate (per 100,000 population)
400
Male
Female
320 Total
2010 Target
240
160
80
0
1988 90 92 94 96 98 2000 02 04 06
Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000
population.
Gonorrhea — Rates by region: United States, 1998–2007 and the
Healthy People 2010 target
Rate (per 100,000 population)
300
West
Midwest
240 Northeast
South
2010 Target
180
120
60
0
1998 99 2000 01 02 03 04 05 06 07
Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000
population.
Gonorrhea — Rates by state: United States and outlying areas, 2007
57.1
VT 10.3
12.9 18.2 8.9 NH 10.5
33.4 66.9
MA 41.9
18.3 121.5 RI 37.7
33.4 91.7
15.7 153.4
CT 66.4
64.7
NJ 69.6
102.1
94.4 81.1 DE 151.5
183.5
32.2 162.2139.2 MD 120.5
85.8 71.0 51.1 82.0 DC 408.1
82.6 169.0 82.0
Guam 82.4
158.4
188.2 Rate per 100,000
82.1 134.9
91.9 148.3 239.0 population
190.5
285.7 236.7 100 (n= 21)
P uerto Rico 8.2
V irgin Is. 63.5
Note: The total rate of gonorrhea for the United States and outlying areas
(Guam, Puerto Rico and Virgin Islands) was 117.4 per 100,000 population.
The Healthy People 2010 target is 19.0 cases per 100,000 population.
Gonorrhea — Rates by county: United States, 2007
Rate per 100,000
population
100.0 (n= 736)
Note: The Healthy People 2010 target for gonorrhea is 19.0 cases per 100,000 population.
Gonorrhea — Age- and sex-specific rates: United States, 2007
Men Rate (per 100,000 population) Women
750 600 450 300 150 0 Age 0 150 300 450 600 750
5.9 10-14 33.1
286.0 15-19 647.9
450.1 20-24 614.5
305.1 25-29 287.1
181.5 30-34 125.2
119.5 35-39 60.5
86.6 40-44 30.8
50.2 45-54 12.1
17.7 55-64 3.0
4.0 65+ 0.4
113.9 Total 123.8
Gonorrhea — Age-specific rates among women 15 to 44 years of age:
United States, 1998–2007
Rate (per 100,000 population)
1,000
15-19 20-24
25-29 30-34
35-39 40-44
800
600
400
200
0
1998 99 2000 01 02 03 04 05 06 07
Gonorrhea — Age-specific rates among men 15 to 44 years of age:
United States, 1998–2007
Rate (per 100,000 population)
750
15-19 20-24
25-29 30-34
35-39 40-44
600
450
300
150
0
1998 99 2000 01 02 03 04 05 06 07
Gonorrhea — Rates by race/ethnicity: United States, 1998–2007
Rate (per 100,000 population)
900
720
540 American Indian/AK Native
Asian/Pacific Islander
Black
Hispanic
360 White
180
0
1998 99 2000 01 02 03 04 05 06 07
Gonorrhea — Cases by reporting source and sex: United States, 1998–2007
Cases (in thousands)
200
non-STD Clinic Male
non-STD Clinic Female
STD Clinic Male
160 STD Clinic Female
120
80
40
0
1998 99 2000 01 02 03 04 05 06 07
Gonorrhea — Positivity among 15- to 24-year-old women tested in family planning
clinics by state: United States and outlying areas, 2007
0.5
VT 0.1
0.8 0.1 NH 0.1
0.5
MA
0.2 4.9 RI
0.5
0.2 1.7
CT 0.6
0.6
NJ 1.4
0.9
0.8 0.9 DE 1.1
1.8
1.1 1.6 1.6 MD
1.1 0.6 1.2 DC
0.9 1.3 0.7
1.5
0.9
0.8 0.8 Positivity (%)
0.9 2.0 2.4
3.8 2.7
3.3 See* (n= 8)
2.8
0.4 2.2 =2.0 (n= 9)
P uerto Rico 0.1
V irgin Is. 3.6
*States/areas not meeting minimum inclusion criteria.
Note: Includes states and outlying areas that reported positivity data on at least 500
women aged 15-24 years screened during 2007.
SOURCE: Gonorrhea Prevalence Monitoring Project (Regional Infertility Prevention Projects); Office of Population Affairs; Loc al and
State STD Control Programs; Centers for Disease Control and Prevention
Gonococcal Isolate Surveillance Project (GISP) — Prevalence of ciprofloxacin
resistant Neisseria gonorrhoeae by GISP site, 2004-2007
SEA
POR
MIN
DTR
NYC
CHI
CLE
SFO
DEN CIN BAL PHI
LVG KCY
LAX GRB
LBC RIC
QR N G P revalence
ORA ALB OKC
PHX 50%
ATL
BHM
DAL
25%
SDG
0%
HON NOR
' ' '
' 0 40 50 60 7
TRP
MIA
Note: Not all clinics participated in GISP for the last 4 years. Sites include: ALB=Albuquerque, NM; ATL=Atlanta, GA;
BAL=Baltimore, MD; BHM=Birmingham, AL; CHI=Chicago, IL; CIN=Cincinnati, OH; CLE=Cleveland, OH;
DAL=Dallas, TX; DEN=Denver, CO; DTR=Detroit, MI; GRB=Greensboro, NC; HON=Honolulu, HI; KCY=Kansas
City, MO; LAX=Los Angeles, CA; LBC=Long Beach, CA; LVG=Las Vegas, NV; MIA=Miami, FL;
MIN=Minneapolis, MN; NOR=New Orleans, LA; NYC=New York City, NY; OKC=Oklahoma City, OK;
ORA=Orange County, CA; PHI=Philadelphia, PA; PHX=Phoenix, AZ; POR=Portland, OR; SDG=San Diego, CA;
SEA=Seattle, WA; SFO=San Francisco, CA; and TRP=Tripler Army Medical Center, HI
Gonococcal Isolate Surveillance Project (GISP) — Penicillin, tetracycline, and
ciprofloxacin resistance among GISP isolates, 2007
Note: PenR=penicillinase producing N. gonorrhoeae and chromosomally mediated
penicillin-resistant N. gonorrhoeae; TetR=chromosomally and plasmid mediated
tetracycline-resistant N. gonorrhoeae; QRNG=ciprofloxacin resistant N. gonorrhoeae.
Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria
gonorrhoeae isolates with resistance or intermediate resistance to ciprofloxacin,
1990–2007
Percent
16
Resistance
12 Intermediate resistance
8
4
0
1990 91 92 93 94 95 96 97 98 99 2000 01 02 03 04 05 06 07
Note: Resistant isolates have ciprofloxacin MICs ≥ 1 µg/ml. Isolates with
intermediate resistance have ciprofloxacin MICs of 0.125 - 0.5 µg/ml.
Susceptibility to ciprofloxacin was first measured in GISP in 1990.
Gonococcal Isolate Surveillance Project (GISP) — Percent of Neisseria
gonorrhoeae isolates with resistance to ciprofloxacin by sexual behavior,
2001–2007
Percent
40
Heterosexual men
32 Men who have sex with men (MSM)
24
16
8
0
2001 2002 2003 2004 2005 2006 2007